Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes.

Diabetologia

Division of Endocrinology, Diabetes and Bone Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1055, New York, NY, 10029, USA.

Published: April 2017

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-017-4225-3DOI Listing

Publication Analysis

Top Keywords

erratum non-metabolisable
4
non-metabolisable insulin
4
insulin glargine
4
glargine promote
4
promote breast
4
breast cancer
4
cancer growth
4
growth mouse
4
mouse model
4
model type
4

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!